Bio-Rad Laboratories BIO Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 51.9%-1.9pp | 53.7%+0.3pp | 53.4%-2.5pp | 55.9%-0.2pp | |
| Net margin | 29.4%+101pp | -71.9%-48.0pp | -23.9%+106pp | -129.4%-275pp | |
| Free cash flow margin | 14.5%+3.2pp | 11.3%+3.1pp | 8.2%— | —— | |
| Returns | |||||
| Return on equity | 10.8%+34.9pp | -24.1%-17.1pp | -6.9%+24.2pp | -31.1%-67.2pp | |
| Return on assets | 7.6%+24.6pp | -17%-12.1pp | -4.9%+18.2pp | -23.2%-50.8pp | |
| Return on invested capital | 10.7%+7.6pp | 3.1%-0.2pp | 3.3%-0.7pp | 4%-0.4pp | |
| Efficiency | |||||
| Asset turnover | 0.3×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Inventory turnover | 1.7×+0.1× | 1.5×-0.1× | 1.7×-0.3× | 1.9×-0.2× | |
| Liquidity | |||||
| Current ratio | 5.6×-0.9× | 6.5×+0.6× | 5.8×+0.3× | 5.6×+2.6× | |
| Quick ratio | 4.2×-0.7× | 4.9×+0.5× | 4.3×0.0× | 4.3×+2.2× | |
| Cash ratio | 1×0.0× | 1×+0.3× | 0.8×0.0× | 0.8×+0.1× | |
| Leverage | |||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.1×+0.1× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×+0.1× | |
| Interest coverage | 22.6×+17.1× | 5.5×-1.3× | 6.8×-5.8× | 12.7×-310× | |
| Per Share | |||||
| Book value per share | $273.22+17.3% | $232.84-22.2% | $299.26-7.3% | $322.82-28.7% | |
| Valuation | |||||
| Market capitalization | $8.17B-11.1% | $9.2B-2.3% | $9.41B-25.0% | $12.54B-44.5% | |
| Enterprise value | $9.03B-10.5% | $10.09B-3.2% | $10.42B-22.8% | $13.5B-39.6% | |
| Price / earnings | 10.8×— | —— | —— | —— | |
| Price / sales | 3.2×-0.4× | 3.6×+0.1× | 3.5×-1.0× | 4.5×-3.3× | |
| Price / book | 1.1×-0.3× | 1.4×+0.3× | 1.1×-0.2× | 1.3×-0.3× | |
| EV / sales | 3.5×-0.4× | 3.9×0.0× | 3.9×-0.9× | 4.8×-2.8× | |
| Free cash flow yield | 4.6%+1.4pp | 3.1%+0.8pp | 2.3%— | —— | |
| Earnings yield | 9.3%+29.3pp | -20.1%-13.3pp | -6.8%+22.2pp | -28.9%-47.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bio-Rad Laboratories's profit margins?
- Bio-Rad Laboratories (BIO) runs a 51.9% gross margin and a 8.8% operating margin, with a 6.5% net margin.
- Where do Bio-Rad Laboratories's ratios come from?
- Every ratio is computed from Bio-Rad Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
